Fairmount Funds Management LLC
12 holdingsFiling period: 2026-06-30Current AUM: $1.29Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ORKA | Oruka Therapeutics Inc | 3.71M | $352.6M | $293.0M | 22.69% | -- | 2026-06-30 |
| 2 | DNTH | Dianthus Therapeutics Inc | 2.54M | $247.3M | $199.8M | 15.47% | -- | 2026-06-30 |
| 3 | DMRA | Damora Therapeutics Inc | 8.71M | $226.6M | $180.1M | 13.94% | -- | 2026-06-30 |
| 4 | COGT | Cogent Biosciences Inc | 5.50M | $213.0M | $171.9M | 13.31% | -- | 2026-06-30 |
| 5 | JBIO | Jade Biosciences Inc | 4.55M | $101.2M | $67.7M | 5.24% | -- | 2026-06-30 |
| 6 | ELVN | Enliven Therapeutics Inc | 1.86M | $94.2M | $76.5M | 5.93% | -- | 2026-06-30 |
| 7 | VRDN | Viridian Therapeutics Inc | 5.09M | $93.5M | $114.2M | 8.84% | +1.18M | 2026-06-30 |
| 8 | ZBIO | Zenas Biopharma Inc | 2.36M | $59.9M | $66.5M | 5.15% | -- | 2026-06-30 |
| 9 | — | Crescent Biopharma Inc. | 2.75M | $49.5M | $49.5M | 3.83% | -- | 2026-06-30 |
| 10 | APGE | Apogee Therapeutics Inc | 298.6K | $39.6M | $39.6M | 3.07% | -- | 2026-06-30 |
| 11 | SNSE | Faeth Therapeutics Inc | 722.0K | $18.1M | $18.1M | 1.40% | -- | 2026-06-30 |
| 12 | IKT | Inhibikase Therapeutics Inc | 8.63M | $17.5M | $14.7M | 1.14% | -- | 2026-06-30 |
← Scroll →